| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Devonian Health Group Inc (V: GSD)
GSD Technical Analysis
3
| As on 19th Dec 2024 GSD STOCK Price closed @ 0.19 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.19 & Sell for SHORT-TERM with Stoploss of 0.24 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GSDSTOCK Price
| Open | 0.18 | Change | Price | % |
| High | 0.19 | 1 Day | 0.01 | 5.56 |
| Low | 0.18 | 1 Week | -0.03 | -13.64 |
| Close | 0.19 | 1 Month | 0.03 | 18.75 |
| Volume | 36000 | 1 Year | 0.03 | 18.75 |
| 52 Week High 0.28 | 52 Week Low 0.11 | ||||
V Canada Most Active Stocks
| NU | 14.06 | -7.44% |
| WCU | 0.05 | -16.67% |
| QNC | 0.66 | 24.53% |
| THRM | 0.04 | % |
| CANS | 0.01 | % |
| TORQ | 0.06 | 0.00% |
| VTT | 0.02 | 0.00% |
| PGM | 0.02 | 0.00% |
| BTU | 0.02 | 0.00% |
| VXTR | 0.05 | 0.00% |
V Canada Top Gainers Stocks
V Canada Top Losers Stocks
| GSD Daily Charts |
GSD Intraday Charts |
Whats New @ Bazaartrend |
GSD Free Analysis |
|
|
GSD Important Levels Intraday
| RESISTANCE | 0.21 |
| RESISTANCE | 0.20 |
| RESISTANCE | 0.20 |
| RESISTANCE | 0.20 |
| SUPPORT | 0.18 |
| SUPPORT | 0.18 |
| SUPPORT | 0.18 |
| SUPPORT | 0.17 |
GSD Forecast December 2024
| 4th UP Forecast | 0.38 |
| 3rd UP Forecast | 0.32 |
| 2nd UP Forecast | 0.28 |
| 1st UP Forecast | 0.24 |
| 1st DOWN Forecast | 0.14 |
| 2nd DOWN Forecast | 0.1 |
| 3rd DOWN Forecast | 0.06 |
| 4th DOWN Forecast | -0 |
GSD Weekly Forecast
| 4th UP Forecast | 0.34 |
| 3rd UP Forecast | 0.29 |
| 2nd UP Forecast | 0.26 |
| 1st UP Forecast | 0.23 |
| 1st DOWN Forecast | 0.15 |
| 2nd DOWN Forecast | 0.12 |
| 3rd DOWN Forecast | 0.09 |
| 4th DOWN Forecast | 0.04 |
GSD Forecast2024
| 4th UP Forecast | 0.71 |
| 3rd UP Forecast | 0.54 |
| 2nd UP Forecast | 0.44 |
| 1st UP Forecast | 0.34 |
| 1st DOWN Forecast | 0.04 |
| 2nd DOWN Forecast | -0.06 |
| 3rd DOWN Forecast | -0.16 |
| 4th DOWN Forecast | -0.33 |
Devonian Health Group Inc ( V Canada Symbol : GSD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GSD Business Profile
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, a Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric or duodenal ulcers; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, it acquires drug and health product licenses, as well as distributes pharmaceutical products. Devonian Health Group Inc. has a strategic alliance with CannTx Life Sciences Inc. for the development of cannabinoid-based pharmaceutical drugs. The company was incorporated in 2015 and is headquartered in Québec, Canada. Address: 360, rue des Entrepreneurs, Québec, QC, Canada, G5V 4T1
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service